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Chronic pain is a major influence on patient-reported quality of life. This chapter examines 
ways that information from patient-reported outcome measures (PROMs) can be translated 
into clinical practice to improve the management and self-management of chronic pain 
among people with rheumatic disorders and haemophilia. This includes: 1) evidence about 
how PROMs can be used to improve routine clinical practice and self-management 
programmes in rheumatic disorders and haemophilia; 2) evidence about a DVD intervention 
with patient perspectives about living and coping with chronic joint pain, which improved 
patient-reported readiness to self-manage pain; 3) evidence about pain acceptance and pain 
coping as influences on patient-reported quality of life among people with haemophilia; and 
4) recommendations for clinical and treatment interventions to improve patient-reported 




Patient-reported outcomes were defined as “any report of the patient’s health condition that 
comes directly from the patient, without interpretation of the patient’s response by a clinician 
or anyone else” (US Department of Health and Human Services Food and Drug Administration, 
2006). Patient-reported outcome measures (PROMs) include validated questionnaire 
measures that assess the impact of disease and treatment from the perspective of the 
patient. PROMs were originally developed for group comparisons in clinical trials and 
population studies, and the results were used to support treatment recommendations or 
inform health policy, with no direct clinical benefit for the patients who reported the 
outcomes. However, as experience with PROMs increased, the clinical value of using 
individual PROM profiles in routine practice to identify and monitor symptoms, evaluate 
treatment outcomes and support shared decision-making became more apparent (Santana 
et al., 2015).  
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Using PROMs in this way could potentially improve the diagnosis of medical conditions 
and the recognition of problems, and improve patient-physician communication, but 
considerable work still needs to be done to ensure that PROMs are used systematically and 
consistently to achieve those benefits. The value of PROMs is increasingly recognized for 
patient-centred approaches to care, but more well-controlled trials are needed to inform the 
ways that clinicians use PROMs in clinical practice (Valderas, 2008). For example, 
identification of goals, selection of patients and measures, timing of assessments, 
interpretation of scores, development of strategies for responding to PROMs, and evaluation 
of the impact of PROM use were among the issues identified in the User’s Guide for 
Implementing Patient-Reported Outcomes Assessment in Clinical Practice produced by the 
International Society for Quality of Life Research (Snyder et al., 2012).  
In this chapter we consider how PROMs could be used to improve clinical care and 
promote greater patient self-management in two chronic pain conditions: rheumatic 
disorders and haemophilia. We first introduce the use of PROMs in routine clinical practice 
and explain their importance in self-management programs. We then discuss more 
specifically the role of PROMs in self-management of chronic pain, focusing specifically on 
pain coping and acceptance as influences on patient-reported quality of life, and discuss the 
importance of improving the use of PROMs among people with chronic painful conditions. 
 
Using PROMs in routine clinical practice 
 
Patient-reported outcome measures (PROMs) are especially important in the clinical 
management of chronic pain conditions because pain is a uniquely subjective phenomenon 
and patient self-management has an important influence on chronic pain treatment 
outcomes. In other medical contexts, PROMS have been used for screening, promoting 
patient-centred care, aiding decision-making, facilitating multidisciplinary communication, 
and monitoring the quality of patient care (Greenhalgh, 2009). Reviews of evidence about the 
use of PROMs concluded that they have been used more frequently and more effectively to 
detect and assess problems with patients’ health-related quality of life than for patient 
management or to influence patient outcomes (Greenhalgh, 2009; Greenhalgh and 
Meadows, 1999). However, few of those studies included people with chronic pain 
conditions, and none to our knowledge involved people with haemophilia, who are mostly 
treated in specialist centres. In one review of 38 trials evaluating PROMs in clinical practice, 
25 involved primary rather than specialist care, and 13 involved mental health problems. Only 
four of the trials involved patients with chronic illnesses, and none focused specifically on 
rheumatic disorders or haemophilia (Marshall et al., 2006). 
However, several studies of PROMs have included aspects of pain management. One 
study evaluated an intervention for primary care patients with diverse pain and psychosocial 
problems, in which doctors received feedback about patients' problems and concerns. A 
nurse-educator then telephoned patients to teach problem-solving strategies and basic pain 
management skills, which led to improved outcomes (Ahles et al., 2006). Another study 
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showed that the use of patient health status assessment by primary care clinicians in a health 
maintenance organization led to improved patient ratings of the help they received with 
managing pain (Wasson et al., 1992).  
Greenhalgh et al. (2005, p. 839) argued that for PROM-based interventions to be 
effective in routine clinical care, three implicit assumptions must be met: that patients want 
to talk about their health status with clinicians; that clinicians feel it is appropriate to discuss 
health-related quality of life issues with patients; and that clinicians see that information as 
sufficiently important to prompt changes in patients’ treatment or management. Fung and 
Hays (2008) argued that making more use of PROMs, especially quality of life measures, can 
improve the quality of patient care, but that clinicians may not be motivated to make greater 
use of patient-reported measures, and that most health-related quality of life measures were 
developed for research rather than clinical practice. 
 
Using PROMs in routine clinical practice for rheumatology 
 
Rheumatic diseases affect the joints and muscles. Some, like osteoarthritis (OA), damage joint 
cartilage and, as the cartilage wears down, the joints hurt and become harder to move. OA 
‘flares’ are painful exacerbations of inflammatory activity in the affected joints (Bingham et 
al., 2009). OA affects large numbers of people in the world and is one of the most common 
causes of pain, accounting for around 50% of clinical consultations for pain (Brooks, 2006). 
Over the last 10 years, PROMs have been developed to assess symptoms associated 
with specific rheumatic conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing 
spondylitis, and specific patterns of symptoms, especially the ‘flare’. This is important because 
whereas physicians are more likely to base treatment decision-making on objective changes, 
patients are more concerned about subjective changes such as pain, mood disturbance, or 
the need to seek help (Bingham et al., 2009). Organizations including the American College of 
Rheumatology, the European League against Rheumatism, and the Outcome Measures in 
Rheumatology (OMERACT) group, recommended considering both perspectives because they 
provide different but often complementary information (Sanderson et al., 2010). For 
example, a recently developed tool integrates patient and physician perspectives to assess 
current or recent rheumatoid arthritis flares, and is suitable for daily clinical practice to 
identify and monitor both transient and long lasting increases in rheumatoid arthritis 
symptoms (Berthelot et al., 2012). 
Several tools have been used to measure health-related quality of life (HRQOL) among 
patients with osteoarthritis of the lower limbs and those undergoing total hip or knee surgery. 
The Medical Outcomes Study Short-Form 36 (SF36) has been widely applied but, as a generic 
instrument, tends to be less responsive than specific instruments, particularly in the context 
of medical or rehabilitation intervention rather than joint replacement. Comparisons of the 
SF36 with the disease-specific Western Ontario and McMaster Universities Arthritis Index 
(WOMAC) for patients undergoing knee replacement surgery reported that they measured 
different aspects of health and should probably be used together (Hawker et al., 1995). The 
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Arthritis Impact Measurement Scales (AIMS2) tool and its short form AIMS2-SF have been 
considered for use in osteoarthritis but have a limited usefulness among patients with a high 
prevalence of lower limb disability (Guillemin et al., 1997; Ren et al., 1999). Also, combining 
the SF36 with the WOMAC or the Lequesne index (Rat et al., 2005) may not capture specific 
aspects of HRQoL experienced by patients with osteoarthritic knee and hip problems, 
whereas the knee and hip osteoarthritis quality of life questionnaire (OAKHQOL) is specifically 
designed for that purpose (Rat et al., 2005). 
Recently, Golightly et al. (2015) developed a list of recommended PROMs that could 
feasibly be applied in common clinical settings for the management of hip and knee 
osteoarthritis. Suitable PROMs were categorized across the four domains of pain, function, 
fatigue and sleep. The PROMs were also ranked into three tiers: 1) very brief measures for 
initial use in clinical settings; 2) brief measures with more in-depth assessment; 3) more 
detailed assessment. This three-tiered approach provides a basis for tools to systematically 
track outcomes, facilitate provider–patient dialogue, and guide treatment for hip or knee 
osteoarthritis. First, tier 1 measures, particularly for pain, can be used to detect early joint 
symptoms within primary care settings. Second, tiered PROMs provide a way to track 
symptoms over time and guide treatment among patients with established osteoarthritis. For 
example, tier 2 PROMs could detect emerging or advancing sleep problems, triggering referral 
to a specialist for additional evaluation or management. Third, tiered PROMs can be used to 
assess the effectiveness of new treatments. The recommended PROMs may serve as clinical 
tools to systematically screen for and monitor outcomes associated with knee or hip 
osteoarthritis, promote and support provider–patient dialogue about osteoarthritis-related 
outcomes, and guide osteoarthritis treatment. 
 In other work, a review of patient-centred care for rheumatoid arthritis (RA) 
concluded that fatigue should be included as a routine patient-reported outcome because of 
its significance to patients and its responsiveness to treatment (Matcham et al., 2015). The 
psychological correlates of fatigue include affect, mental disorders, RA-related cognitions, 
non-RA related cognitions, personality traits, stress, coping, social support and interpersonal 
relationships. Early identification and management may prevent acute fatigue from becoming 
chronic. There are a range of different patient-report measures of fatigue, which can be 
assessed when patients first present to primary and secondary care, and then continually 
monitored throughout the course of treatment (Matcham et al., 2015). 
Personal factors such as self-efficacy, optimism, resilience and coping strategies are 
also important in the life stories of people with RA, but only 55% of PROMS covered personal 
factors (Dür et al., 2015). Coping strategies and reflecting about one’s life in an optimistic way 
were the personal factors covered most frequently, while job satisfaction was not covered by 
any PROM. Dur et al. concluded that when evaluating personal factors important to people 
with RA, health professionals should be alert to which PROMs can be used to assess which 





Using PROMs in routine clinical practice for haemophilia 
 
Haemophilia is an inherited bleeding disorder caused by deficiencies of blood clotting factors. 
Haemophilia A (caused by factor VIII deficiency) and haemophilia B (caused by factor IX 
deficiency) are both sex-linked recessive disorders in which the classic pattern of transmission 
is from carrier mother to affected son. Haemophilia A affects about one in 5,000 males, and 
haemophilia B about one in 30,000 males (Kliegman, 2011). Prevalence rates vary 
considerably between countries and over time (Stonebraker et al., 2010), but in 2012 there 
were 6,742 people identified with haemophilia in the UK, 6,035 in France, 4,660 in Germany, 
and 18,628 in the USA (World Federation of Hemophilia, 2013). 
People with haemophilia are susceptible to haemarthroses (joint bleeds), which 
happen when small blood vessels in the joint are ruptured and the joint space fills with blood, 
causing severe acute pain. Recurrent joint bleeds damage the joints, leading to arthropathy 
and severe chronic pain (Acharya, 2012). Bleeds and arthropathy can be prevented or 
minimised by early prophylactic (preventative) clotting factor treatment (Rodriguez-Merchan, 
2012). A survey of over 5,000 adults with haemophilia in Europe showed that 67% had 
arthropathy and 35% had chronic pain (Holstein et al., 2012), and one in the USA showed that 
39% of people with haemophilia believed their pain was not well treated (Witkop et al., 2012).  
In haemophilia, there has been considerable use of PROMs such as the SF-36, which 
is a very widely used measure of health-related quality of life that meets most of the minimum 
standards criteria for PROM measures (Reeve et al., 2013). Studies have shown that people 
with haemophilia have poorer physical health-related quality of life than the general 
population (Fischer et al., 2003; Szende et al., 2003) and that physical health-related quality 
of life is poorer among people with haemophilia who have more joint damage or are not 
receiving prophylactic clotting factor treatment (Fischer et al., 2005; Royal et al., 2002; 
Solovieva, 2001). However, mental quality of life is less affected by haemophilia and is less 
closely associated with joint status (Poon et al., 2012; Zhou et al., 2011).  
Research with PROMs has influenced overall standards of care for haemophilia, for 
example by demonstrating the value of prophylactic clotting factor treatment. This in turn led 
to more efforts to involve patients in self-management, for example by self-administering 
clotting factor (Stover, 2000). More recently have there been efforts to use PROMS more 
directly to inform individual treatment and management. In one example, a doctor used a 
health-related quality of life PROM to help decide about treatment with prophylaxis 
(preventative treatment to avoid bleeding episodes): “You discuss the impact of hemophilia 
on his health-related quality of life (HRQOL) and consider measuring his HRQOL over time 
using a generic measure of HRQOL to determine whether prophylaxis will reduce interruptions, 
pain, and lost time from work and improve his HRQOL.” (Buchbinder and Ragni, 2013, p. 52). 
The main emphasis in the use of patient-reported quality of life measures so far has 
therefore been the prevention of joint bleeds and chronic joint pain, rather than the self-
management of chronic pain, but there is now more emphasis on chronic pain management 
and self-management. Some analyses called for a more standardised approach to assessing 
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and managing pain in haemophilia, based on good practice guidelines and recommendations 
(Riley et al., 2011). Others recommended more individualised, multi-modal approaches, 
which would enable individual patient-reported information to inform treatment decisions 
and clinical management: “Ongoing psychosocial assessment is critical to identify those 
factors that may be contributing to the perpetuation of chronic pain or acting as barriers to 
effective management” (Young et al., 2013, p. 113).  
However, that approach will probably require PROMs other than generic measures of 
health-related quality of life. One review of PROMs more generally concluded that generic 
measures like the SF-36 may not be clinically relevant enough to prompt clinicians to make 
changes to patient management (Greenhalgh and Meadows, 1999), and the same conclusion 
has been reached in the context of haemophilia. One review concluded that generic measures 
such as the SF-36 were not specific or responsive enough to changes in health status, and that 
a haemophilia-specific tool was needed to focus on specific features of haemophilia while 
also taking account of common comorbidities such as hepatitis and HIV, as well as arthropathy 
(Szende et al., 2003). Because arthropathy is so common in haemophilia, this might involve 
incorporating parts of arthritis-specific scales, although it would be important to recognise 
that arthropathy in haemophilia is different from primary arthritis; for example, it rarely 
affects the fingers and hands (Szende et al., 2003). Condition-specific quality of life measures 
have been developed for haemophilia (Remor et al., 2004), but they are not widely used so 
far. 
 
Using PROMs more effectively in routine clinical practice 
 
For both rheumatic conditions and haemophilia, integrating PROMs in clinical practice has the 
potential to enhance patient-centred care and improve patients’ self-management. However, 
a key issue limiting successful implementation may be clinicians’ lack of knowledge on how 
to effectively utilize PROMs data in their clinical encounters (Santana et al., 2015). An analysis 
of consultations between oncologists and their patients suggested that the main obstacles for 
enhancing the use of PROMs for making changes in clinical care may be limitations in the 
collection and interpretation of PROM data. The study concluded that “explicit mention of 
PROM data in the consultation may strengthen opportunities for patients to elaborate on their 
problems, but that doctors may not always know how to do this” (Greenhalgh et al., 2013). A 
model for PROMs in clinical practice was proposed that combined standard questionnaires 
with disease-specific or treatment-specific items, plus a prompt list of items, in order to 
facilitate discussion of individual-specific issues and minimize patient burden (Velikova et al., 
2008). One review of sixteen qualitative studies on the experiences of professionals using 
PROMs concluded that the key ways to facilitate greater use of PROMs were to make the 
collection of PROM data part of normal work routines, and to give the PROMs data meaning 
by using them to make changes to patient care (Boycel et al., 2014).  
A model for implementing changes in clinical practice proposed combining several 
approaches, including experiential learning; producing evidence-based guidelines; adapting 
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training for specific audiences; reviewing performance and giving feedback and reminders; 
supporting care providers and key opinion formers; and promoting organisational innovation 
(Grol, 1997). More recently, Santana et al. (2015) described the development and 
implementation of three programs for training clinicians to use PROM data effectively in 
routine practice, which aimed to identify the key components for successful clinician training. 
The programs were in diverse clinical areas (adult oncology, lung transplant and paediatrics), 
and in three countries with different healthcare systems, providing a rare opportunity to 
extract common approaches whilst recognizing specific settings. The programs showed that 
clinicians with different professional backgrounds can be successfully trained to use PROMs 
effectively in clinical practice using brief training programs to help them interpret and act on 
PROM data (Santana et al., 2015).  
 
Self-management programmes and PROMs 
 
Self-management is important in chronic illness because those affected must learn to live with 
and manage their condition. Self-management programmes “usually consist of organized 
learning experiences designed to facilitate adoption of health-promoting behaviors” (Warsi et 
al., 2004, p. 1641). This can include the optimal use of drugs, exercise, nutrition and other 
preventative and health behaviours, as well as communicating effectively with health 
professionals, family and/or caregivers, and learning techniques to address both the physical 
and emotional challenges caused by chronic illness (Newman et al., 2004).  
Evidence about the effectiveness of self-management interventions differs between 
conditions. There is evidence they are beneficial for people with asthma, diabetes or 
hypertension but have smaller effects for people with arthritis (Chodosh et al., 2005; Warsi 
et al., 2003; 2004). More recently, one review also concluded that people with rheumatoid 
arthritis receive only marginal benefits from participation in chronic disease self-management 
interventions, and that although the intervention programme appeared to have worked in 
some cases, the data actually showed only small effects, which perhaps raises questions 
about the measures used in the evaluation of such programs (Nolte et al., 2013). 
  A wide variety of intervention programs have been developed to enable patients to 
become more independent in managing their disease and take appropriate decisions for a 
more active and fulfilling life (Nolte and Osborne, 2013) and PROM data can be useful at 
several stages of interventions. Firstly, before the intervention begins, PROMs can be used to 
assess patients’ resources and skills, so that the interventions can be made more effective 
and more focused by taking account of individual patient profiles. The World Health 
Organization recommends developing psycho-educational diagnoses to define personalized 
self-management programs (WHO, 1998). PROMs can help to understand the different 
aspects of a patient's life, personality, goals and needs, by making subjective assessments of 
the impact of life events and representations of the disease, as well as self-efficacy, coping 
strategies, motivation and other factors, including respondents’ perceptions of what it would 
take for them to change their behaviour (Michie et al., 2014).  
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Secondly, PROMs can be used to monitor patients’ progress during self-management 
interventions, and the results can inform possible adjustment or reframing of the 
intervention. For several years, researchers and clinicians worked to develop a Taxonomy of 
behaviour change techniques that could be applied to many different types of behaviour 
change interventions across different disciplines and countries, including organizational and 
community interventions (Michie et al., 2005; 2013).  
Thirdly, at the end of the intervention, as the WHO recommends for therapeutic 
patient education, PROMs can be used to evaluate the overall effectiveness of the 
programme, and assess changes in patients’ skills and adaptation. Thus, at the different stages 
of self-management programs, there is value in enabling enable a standardized evaluation 
throughout the intervention.  
PROMs can also be fully integrated into the intervention. The integration of PROMS 
and self-management for patients with inflammatory arthritis in a joint-fitness program 
succeeded in improving self-perceived health as well as disease activity (El Miedany et al., 
2012). Integrating PROMs with patient education is also feasible in standard clinical practice, 
and empowering patients through education may allow them to be more proactive in seeking 
better evidence based medical treatments at an earlier stage (Vermaak et al., 2015).  
 
PROMs and chronic pain self-management 
 
For assessment and evaluation of pain it may be useful to adopt or adapt patient-reported 
measures that have been employed in other chronic pain conditions (Humphries and Kessler, 
2013). For chronic pain self-management, and to improve PROMs, it is also important to know 
about how people think and feel about their pain, and those aspects can be assessed using 
standardised self-report measures of knowledge, attitudes, beliefs and behaviours., including 
pain coping, pain acceptance, and readiness to self-manage pain. For two decades, Cognitive-
Behavioural Therapy (CBT), more especially Acceptance and Commitment Therapy (ACT; 
Hayes et al., 1999) and physical activity promotion have emerged as major tools in the 
treatment of patients with chronic pain. Harlacher et al. (2011) examined whether 
Multidimensional Pain Inventory (MPI) subscale score changes could be used for monitoring 
pain rehabilitation programmes, using the Psychological General Well-Being (PGWB) index as 
a separate measure of rehabilitation outcome. They proposed combining the scores from four 
MPI subscales, and using pre-to-post differences in PGWB scores to indicate composite 
rehabilitation outcomes. One study also showed that patients' beliefs about the nature and 
treatment of their pain could change during participation in a multidisciplinary pain 
management programme, and that modification of those beliefs may be associated with 
improvements in patients' perceptions of the level of their disability (Walsh and Radcliffe, 
2002). 
For managing chronic pain, it is necessary to evaluate the patient’s beliefs. Most often, 
PROMs are used to identify cognitive errors in patients’ thinking and to understand the 
relation between thoughts, emotions and pain. Otis (2003) proposed using the ABC 
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Worksheet to identify patients’ beliefs and perceived consequences associated with pain.  In 
the ABC Workshop, A is for Activating Event (the stressful situation associated with pain). B is 
for beliefs (the things you tell yourself, and the thoughts you have about the pain situation). 
C is for Consequences (reactions to pain, which can be emotional, physical or behavioural, or 
all three). Patients may begin to see that negative thoughts make the experience of pain 
worse, and then learn to replace negative thoughts with more positive thoughts. This will help 
reduce negative emotions and can result in decreased pain. The assessment of cognitive 
distortions can be realized using Beck et al.’s (1991) Dysfunctional Attitudes Scale (DAS). 
To manage chronic pain, it is also necessary to evaluate and regulate the emotional 
processes associated with pain. Emotional intelligence (EI), which refers to individual 
differences in the abilities to identify, assess, understand, express, regulate and use emotional 
information, and can be applied separately to the emotions of oneself and others, has been 
found to be an important predictor of pain management and adaptation to environment 
(Mikolajczak et al., 2014). The Profile of Emotional Competence (PEC) measures the skills 
required to identify, give meaning to and manage the emotions associated with pain (Brasseur 
et al., 2013). Through analysis of PROMs like the PEC, the multidisciplinary team can offer a 
targeted intervention to develop or strengthen the emotional competences of the chronic 
pain patient. Following this assessment of emotional skills, different types of interventions 
can be offered with the purpose of regulating the emotions associated with pain. For example, 
an integrative intervention (Positive Emotion Regulation program) was designed to help 
clinicians implement interventions and techniques that target different emotional processes 
Weytens et al. (2014). The emotional processes involved are structured around a theoretical 
framework (Gross, 1998; Quoidbach et al., Gross, 2013). Other forms of intervention can be 
proposed which are based on the Emotion-Focused Therapy (EFT) (Greenberg, 2002; 
Greenberg and Pascual-Leone, 2006).  
  In haemophilia is it vitally important to differentiate chronic joint pain from acute 
bleeding pain, for acute bleeding pain should be treated promptly with clotting factor. 
However, people with haemophilia may sometimes not make this distinction. In one study, 
people with haemophilia used similar descriptors for acute and chronic pain, and many 
reported using clotting factor to treat chronic pain, or failed to use factor treatment to treat 
acute pain (Witkop et al., 2011).  
The key elements of chronic joint pain self-management for people with haemophilia 
are sometimes summarized as Rest, Ice, Compression and Elevation (RICE). (Compression 
means applying pressure to the painful area, and elevation means raising the affected limb.) 
Those four things were in fact the most frequently used pain management strategies among 
a US sample of people with haemophilia (Witkop et al., 2012). Among people with 
haemophilia in the Netherlands, 36% of those with joint pain used analgesics (painkillers) (van 
Genderen et al., 2006). In Germany, 76% of people with severe haemophilia took analgesics 
daily (Wallny et al., 2001). In the UK, 53% of people with haemophilia used over-the-counter 
analgesics and 34% used prescription analgesics in the last month (Elander and Barry, 2003). 
Knowledge about analgesics is important because certain pain medications can cause 
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complications for people with haemophilia (Holstein et al., 2012), but there is surprisingly 
little research evidence about patients’ or practitioners’ knowledge and beliefs about pain 
relief for people with haemophilia, or about how they can be improved to increase the quality 
of haemophilia-related joint pain management. 
In other painful chronic conditions, self-management interventions in the form of 
small-group education sessions, often drawing on principles from cognitive-behavioural 
therapy, have been developed and evaluated (Moore et al., 2000; Von Korff et al., 1998; 
Barlow et al., 2000). Considerable attention has also focused on increasing motivation or 
‘readiness’ to self-manage pain, for self-management programs are limited by participants’ 
readiness to self-manage. Readiness to self-manage chronic pain can be measured using a 
standardised patient-report questionnaire (Kerns et al., 1997). In the motivational model of 
pain self-management, a number of factors influence readiness to self-manage, and readiness 
to self-manage then influences self-management behaviours (Jensen et al., 2003).  
One intervention to improve readiness to self-manage chronic joint pain among 
people with haemophilia comprised an information booklet and DVD (Elander et al., 2011). 
The booklet described the difference between acute bleeding pain and chronic arthritic joint 
pain, the impact of pain on emotions and other aspects of life, the benefits and risks of using 
pain medication, and the benefits of active self-management and exercise. The DVD was 
based very directly on patient-reported information; all the content was presented by five 
men with haemophilia who described their own experiences of living with joint pain, including 
its impact on their lives and how they had adjusted their life goals and values accordingly. The 
information was consistent with the motivational model of pain self-management, but the 
emphasis on direct patient reports was intended to increase viewers’ motivation to self-
manage their chronic joint pain (Elander et al., 2011).   
The booklet and DVD were evaluated in a 6-month trial in which all the participants 
received the booklet and a randomly selected half also received the DVD. Compared with 
those who received only the booklet, patient-reported readiness to self-manage improved 
among those who received the DVD. Active pain coping also increased among participants 
generally, and active involvement in learning pain self-management strategies and 
incorporating those strategies in everyday life increased among those who reported reading 
or watching the materials (Elander et al., 2011). Evidence like this suggests that self-
management can be improved by giving patients a role in communicating information about 
their experiences, and by incorporating patient-reported outcomes directly into the materials 
used in interventions.  
 
Pain coping and acceptance as influences on patient-reported outcomes 
 
Pain coping usually means the characteristic ways that people approach and respond to pain 
in order to control or avoid it, and is typically assessed using standardised patient-report 
questionnaires (Jensen et al., 1991).  For people with haemophilia, a condition-specific 
patient-report measure of pain coping has been developed and evaluated (Barry and Elander, 
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2002; Elander and Robinson, 2008). The ways that people with haemophilia coped with pain 
was similar to people with other painful chronic conditions (Barry and Elander, 2002; 
Santavirta et al., 2001), and active pain coping (using active behavioural or cognitive 
strategies) was associated with greater readiness to self-manage pain, whereas negative 
thoughts about pain and passive pain coping were associated with less readiness to self-
manage pain (Elander and Robinson, 2008). Negative thoughts about pain were associated 
with beliefs that chance factors were responsible for pain control and with concerns about 
drug use, whereas passive pain coping was associated with beliefs about doctors being 
responsible for pain control, more frequent visits to healthcare professionals, and greater use 
of analgesic medication (Barry and Elander, 2002; Elander and Barry, 2003).  
However, in much chronic pain research the emphasis has turned in recent years from 
pain coping to pain acceptance, because attempts to control or avoid pain can lead to 
negative outcomes when they are unsuccessful, as they may often be when pain is chronic. 
Pain acceptance means recognizing that pain cannot always be avoided or controlled and that 
pain should not prevent efforts to engage with other valued goals and activities (McCracken 
and Eccleston, 2003). Among people with more common chronic pain conditions, research 
often shows that acceptance rather than coping is a better predictor of outcomes, including 
patient-reported outcomes (McCracken and Eccleston, 2006).    
We know of only two studies of patient-reported outcomes among people with 
haemophilia that included measures of both pain coping and pain acceptance, and both of 
these showed that pain intensity affected physical quality of life and pain acceptance 
influenced mental quality of life, whereas active coping did not influence either physical or 
mental quality of life (Elander et al., 2009; Elander et al., 2013). This seems to suggest that 
improvements in patient-reported outcomes for people with haemophilia could be achieved 
by interventions that reduced pain intensity and increased pain acceptance.  
Interventions to improve patient-reported outcomes for people with haemophilia-
related joint pain could focus on reducing pain intensity and increasing pain acceptance, and 
both of those factors could be targeted by clinical practice and treatments that were informed 
by patient-reported outcomes. To reduce pain intensity, pain assessment could be improved 
by adapting patient-reported methods that are used in other chronic pain conditions 
(Humphries and Kessler, 2013), and by educating patients to differentiate acute bleeding pain 
from chronic arthritic pain, so that acute bleeding episodes can be promptly treated with 
clotting factor. Patients could also be informed and educated about analgesics and other pain 
management methods, including published guidance about pain management for people 
with haemophilia (Holstein et al., 2012). 
  To improve pain acceptance, existing programmes designed for people with other 
chronic pain conditions could be refined and adapted for people with haemophilia. These 
typically involve small group exercises including exposure, habit reversal training, mindfulness 
meditation and sensation focusing (McCracken et al., 2005), but pain acceptance must be 
interpreted differently in each context and medical condition (Risdon et al., 2003), so patient-
reported outcomes could very usefully inform the development and adaptation of 
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acceptance-based interventions for people with haemophilia. One technique that could be 
used to achieve this is the clinical pain acceptance Q-sort, which can be used to explore pain 
acceptance in clinical contexts, and can be used as a therapeutic tool to discuss and promote 
pain acceptance in a sensitive, diplomatic way that takes into account patient-reported 
experiences and outcomes (La Cour, 2012).  
A recent review suggested there could be a conflict between the short-term goal of 
providing effective pain relief to reduce pain intensity and the longer-term goal of improving 
pain acceptance (Elander, 2014). The review recommended that interventions should be 
“very carefully designed to take into account the specific needs of the people for whom they 
are intended, and should take specific care not to reduce the importance that should be 
attached to prompt treatment of acute bleeding episodes with clotting factor” (Elander, 2014, 




Most of the research and reflective practice about PROMs generally is applicable to chronic 
pain conditions like rheumatic disorders and haemophilia, so research and practice in those 
conditions might be expected to follow the more general direction of travel for improving 
PROM use. One challenge is to improve the PROMs themselves. Patients are increasingly 
committed to participating in the development and improvement of PROMs, and an 
international exploration of patient engagement in HRQL and PROM research highlighted 
that, in the absence of good practice guidelines, a framework or toolkit to help embed patient 
engagement within health-related quality of life and PROM research is required (Haywood, 
2015). One issue is to ensure that PROMs are suitable for the wide range of people potentially 
affected by their use, including those with low literacy and members of minority cultural and 
ethnic groups (Petkovic et al., 2015). Another is to produce short forms of PROMS that 
preserve their psychometric properties but reduce the time needed to complete them 
(Guillemin, 2016; Goetz et al., 2013). The International Society for Quality of Life Research 
(ISOQOL) may have a key role in taking those ideas forward, by actively engaging with patient 
partners to shape a future ISOQOL patient engagement strategy (Haywood, 2015; Reeve et 
al., 2013). 
A second challenge is to improve the ways PROMs are incorporated in the design and 
development of clinical interventions, in order to improve the quality and effectiveness of 
those interventions.  To achieve this, health professionals may need to be better educated 
about PROM use. Increasing interest among clinicians in using PROMs in their clinical practice 
has led to the development of international registers and consortia that help to reach 
consensus among researchers and practitioners (Breckenridge et al., 2015). A reflection paper 
on the use of PROMs in oncology provides a useful update on design issues common to all 
trial research with PROM endpoints, and could serve as a model for using PROMs in other 
conditions (European Medicines Agency, 2014). Other areas that need to be investigated 
include the use of the Consolidated Standards of Reporting Trials (CONSORT) PROM extension 
13 
 
to drive up standards of reporting, the value of ‘negative’ PROM findings, the need for better 
information about historical labelling decisions, and the role of patients in the PROM trial 
design and implementation (Kyte et al., 2016). All those issues could be usefully applied to 
arthritis and haemophilia. 
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